Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 21

1.

Clinical and prognostic implications of roundabout 4 (robo4) in adult patients with acute myeloid leukemia.

Chen YK, Hou HA, Tang JL, Jhuang JY, Lai YJ, Lee MC, Kuo YY, Chou WC, Liu CY, Lin CW, Chuang SS, Chen CY, Tseng MH, Huang CF, Chiang YC, Lee FY, Liu MC, Liu CW, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF.

PLoS One. 2015 Mar 20;10(3):e0119831. doi: 10.1371/journal.pone.0119831. eCollection 2015.

2.

Adult T-cell lymphoma/leukemia presenting as isolated central nervous system T-cell lymphoma.

Ma WL, Li CC, Yu SC, Tien HF.

Case Rep Hematol. 2014;2014:917369. doi: 10.1155/2014/917369. Epub 2014 Dec 23.

3.

The N-terminal CEBPA mutant in acute myeloid leukemia impairs CXCR4 expression.

Kuo YY, Hou HA, Chen YK, Li LY, Chen PH, Tseng MH, Huang CF, Lee FY, Liu MC, Liu CW, Chou WC, Liu CY, Tang JL, Yao M, Tien HF.

Haematologica. 2014 Dec;99(12):1799-807. doi: 10.3324/haematol.2014.107821. Epub 2014 Sep 5.

4.

Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma.

Huang SY, Lin CW, Lin HH, Yao M, Tang JL, Wu SJ, Chen YC, Lu HY, Hou HA, Chen CY, Chou WC, Tsay W, Chou SJ, Tien HF.

Ann Hematol. 2014 Aug;93(8):1371-80. doi: 10.1007/s00277-014-2063-7. Epub 2014 Apr 1.

5.

A multicentre phase II study of vorinostat in patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma.

Ogura M, Ando K, Suzuki T, Ishizawa K, Oh SY, Itoh K, Yamamoto K, Au WY, Tien HF, Matsuno Y, Terauchi T, Yamamoto K, Mori M, Tanaka Y, Shimamoto T, Tobinai K, Kim WS.

Br J Haematol. 2014 Jun;165(6):768-76. doi: 10.1111/bjh.12819. Epub 2014 Mar 12.

6.

Dynamics of ASXL1 mutation and other associated genetic alterations during disease progression in patients with primary myelodysplastic syndrome.

Chen TC, Hou HA, Chou WC, Tang JL, Kuo YY, Chen CY, Tseng MH, Huang CF, Lai YJ, Chiang YC, Lee FY, Liu MC, Liu CW, Liu CY, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF.

Blood Cancer J. 2014 Jan 17;4:e177. doi: 10.1038/bcj.2013.74.

7.

Clinicopathologic features and responses to radiotherapy of myeloid sarcoma.

Chen WY, Wang CW, Chang CH, Liu HH, Lan KH, Tang JL, Tien HF, Kuo SH, Cheng AL.

Radiat Oncol. 2013 Oct 22;8:245. doi: 10.1186/1748-717X-8-245.

8.

Improving but inferior survival in patients with chronic lymphocytic leukemia in taiwan: a population-based study, 1990-2004.

Wu SJ, Chiang CJ, Lin CT, Tien HF, Lai MS.

PLoS One. 2013 Apr 24;8(4):e62930. doi: 10.1371/journal.pone.0062930. Print 2013.

9.

Clinical and microbiological characteristics of perianal infections in adult patients with acute leukemia.

Chen CY, Cheng A, Huang SY, Sheng WH, Liu JH, Ko BS, Yao M, Chou WC, Lin HC, Chen YC, Tsay W, Tang JL, Chang SC, Tien HF.

PLoS One. 2013;8(4):e60624. doi: 10.1371/journal.pone.0060624. Epub 2013 Apr 5.

10.

Hierarchical cluster analysis of immunophenotype classify AML patients with NPM1 gene mutation into two groups with distinct prognosis.

Chen CY, Chou WC, Tsay W, Tang JL, Yao M, Huang SY, Tien HF.

BMC Cancer. 2013 Mar 8;13:107. doi: 10.1186/1471-2407-13-107.

11.

A knock-in Npm1 mutation in mice results in myeloproliferation and implies a perturbation in hematopoietic microenvironment.

Chou SH, Ko BS, Chiou JS, Hsu YC, Tsai MH, Chiu YC, Yu IS, Lin SW, Hou HA, Kuo YY, Lin HM, Wu MF, Chou WC, Tien HF.

PLoS One. 2012;7(11):e49769. doi: 10.1371/journal.pone.0049769. Epub 2012 Nov 30.

12.

Intracranial hemorrhage in adult patients with hematological malignancies.

Chen CY, Tai CH, Cheng A, Wu HC, Tsay W, Liu JH, Chen PY, Huang SY, Yao M, Tang JL, Tien HF.

BMC Med. 2012 Aug 29;10:97. doi: 10.1186/1741-7015-10-97.

13.

Clinical characteristics and outcomes of Mycobacterium tuberculosis disease in adult patients with hematological malignancies.

Chen CY, Sheng WH, Cheng A, Tsay W, Huang SY, Tang JL, Chen YC, Wang JY, Tien HF, Chang SC.

BMC Infect Dis. 2011 Nov 23;11:324. doi: 10.1186/1471-2334-11-324.

14.

Distinct association between aberrant methylation of Wnt inhibitors and genetic alterations in acute myeloid leukaemia.

Hou HA, Kuo YY, Liu CY, Lee MC, Tang JL, Chen CY, Chou WC, Huang CF, Lee FY, Liu MC, Yao M, Tien HF.

Br J Cancer. 2011 Dec 6;105(12):1927-33. doi: 10.1038/bjc.2011.471. Epub 2011 Nov 17.

15.

Invasive fungal sinusitis in patients with hematological malignancy: 15 years experience in a single university hospital in Taiwan.

Chen CY, Sheng WH, Cheng A, Chen YC, Tsay W, Tang JL, Huang SY, Chang SC, Tien HF.

BMC Infect Dis. 2011 Sep 22;11:250. doi: 10.1186/1471-2334-11-250.

16.

High bone marrow angiopoietin-1 expression is an independent poor prognostic factor for survival in patients with myelodysplastic syndromes.

Cheng CL, Hou HA, Jhuang JY, Lin CW, Chen CY, Tang JL, Chou WC, Tseng MH, Yao M, Huang SY, Ko BS, Hsu SC, Wu SJ, Tsay W, Chen YC, Tien HF.

Br J Cancer. 2011 Sep 27;105(7):975-82. doi: 10.1038/bjc.2011.340. Epub 2011 Aug 30.

17.

Rapid assessment of the heterogeneous methylation status of CEBPA in patients with acute myeloid leukemia by using high-resolution melting profile.

Lin TC, Jiang SS, Chou WC, Hou HA, Lin YM, Chang CL, Hsu CA, Tien HF, Lin LI.

J Mol Diagn. 2011 Sep;13(5):514-9. doi: 10.1016/j.jmoldx.2011.05.002. Epub 2011 Jun 30.

18.

Changes in magnetic resonance bone marrow angiogenesis on day 7 after induction chemotherapy can predict outcome of acute myeloid leukemia.

Hou HA, Shih TT, Liu CY, Chen BB, Tang JL, Yao M, Huang SY, Chou WC, Hsu CY, Tien HF.

Haematologica. 2010 Aug;95(8):1420-4. doi: 10.3324/haematol.2009.019364. Epub 2010 Mar 10.

19.

Reply to 'Heterogeneity within AML with CEBPA mutations; only CEBPA double mutations, but not single CEBPA mutations are associated with favorable prognosis'.

Hou HA, Lin LI, Chen CY, Tien HF.

Br J Cancer. 2009 Aug 18;101(4):738-40. doi: 10.1038/sj.bjc.6605207. Epub 2009 Jul 21. No abstract available.

20.

Marrow angiogenesis-associated factors as prognostic biomarkers in patients with acute myelogenous leukaemia.

Lee CY, Tien HF, Hu CY, Chou WC, Lin LI.

Br J Cancer. 2007 Oct 8;97(7):877-82. Epub 2007 Sep 11.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk